Antithrombotic therapy to support primary PCI

New England Journal of Medicine

Volumn 358, Issue 21, 2008, Pages 2280-2282

  Morrow, David A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; TIROFIBAN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; EDITORIAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART PERFUSION; HUMAN; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION;

EID: 44249117827     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0802383     Document Type: Editorial

References (15)

1. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110(9):e82-e292. [Errata, Circulation 2005;111: 2013-4, 2007;115(15):e411.]
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevationmyocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110(9):e82-e292. [Errata, Circulation 2005;111: 2013-4, 2007;115(15):e411.]
3. GW Stone B Witzenbichler G Guagliumi Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 2008 2218 2230
4. EC Keeley JA Boura CL Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 2003 13 20
5. MS Sabatine CP Cannon CM Gibson Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 2005 1179 1189
6. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117:261-95. [Erratum, Circulation 2008;117(6):e161.]
7. G De Luca H Suryapranata GW Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293 2005 1759 1765
8. HS Gurm DE Smith JS Collins The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. J Am Coll Cardiol 51 2008 529 535
9. S Yusuf SR Mehta S Chrolavicius Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA 295 2006 1519 1530
10. GW Stone BT McLaurin DA Cox Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 2006 2203 2216
11. G Montalescot M Borentain L Payot JP Collet D Thomas Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 292 2004 362 366
12. SD Wiviott E Braunwald CH McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 2007 2001 2015
13. S Yusuf SR Mehta S Chrolavicius Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354 2006 1464 1476
14. SV Manoukian F Feit R Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49 2007 1362 1368
15. FA Spencer M Moscucci CB Granger Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801